Literature DB >> 25600405

Absolute structures and bioactivities of euryspongins and eurydiene obtained from the marine sponge Euryspongia sp. collected at Iriomote Island.

Hiroyuki Yamazaki1, Ohgi Takahashi1, Syu-Ichi Kanno1, Takahiro Nakazawa1, Shiori Takahashi1, Kazuyo Ukai1, Deiske A Sumilat2, Masaaki Ishikawa1, Michio Namikoshi3.   

Abstract

Three unique sesquiterpenes, named euryspongins A-C (1-3), have been isolated from the marine sponge Euryspongia sp. The absolute configuration of 1 was assigned as (4R,6R,9S) by comparing its experimental Electronic Circular Dichroism (ECD) spectrum with the calculated ECD spectra of both enantiomers, and the absolute configurations of 2, 3 and artifact 4 were suggested on the basis of that of 1 by assuming common biogenesis of 1-3. These absolute configurations were opposite to those depicted in the previous communication. Further separation of the remaining fractions lead to the isolation of a new C11-polyketide, named as eurydiene (5), together with a known C11-polyketide, nakitriol (6). The structure of 5 was assigned on the basis of its spectroscopic data as a bicyclic alcohol with a diene side chain. Dehydroeuryspongin A (4) inhibited protein tyrosine phosphatase 1B (PTP1B), an important target enzyme for the treatment of type II diabetes and obesity, with an IC50 value of 3.58μM. Moreover, compound 4 did not inhibit the proliferation of human hepatoma Huh-7 cells at 100μM. One of the locations in which PTP1B has been detected is hepatocytes. Compounds 1-3, 5, and 6 were not active against PTP1B. The growth of human colon (HCT-15) and T-cell lymphoma (Jurkat) cells was not disturbed by compounds 1-6.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Eurydiene; Euryspongia sp.; Euryspongin; Marine sponge; PTP1B

Mesh:

Substances:

Year:  2014        PMID: 25600405     DOI: 10.1016/j.bmc.2014.12.049

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Trichoketides A and B, two new protein tyrosine phosphatase 1B inhibitors from the marine-derived fungus Trichoderma sp.

Authors:  Hiroyuki Yamazaki; Ryo Saito; Ohgi Takahashi; Ryota Kirikoshi; Kengo Toraiwa; Kohei Iwasaki; Yuta Izumikawa; Wataru Nakayama; Michio Namikoshi
Journal:  J Antibiot (Tokyo)       Date:  2015-04-22       Impact factor: 2.649

2.  Marine Sponge Endosymbionts: Structural and Functional Specificity of the Microbiome within Euryspongia arenaria Cells.

Authors:  Qi Yang; Jackson K B Cahn; Jörn Piel; Yue-Fan Song; Wei Zhang; Hou-Wen Lin
Journal:  Microbiol Spectr       Date:  2022-05-02

Review 3.  Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives.

Authors:  Palma Lamonaca; Giulia Prinzi; Aliaksei Kisialiou; Vittorio Cardaci; Massimo Fini; Patrizia Russo
Journal:  Mar Drugs       Date:  2017-03-20       Impact factor: 5.118

Review 4.  Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2019-12-19       Impact factor: 5.118

Review 5.  Exploration of marine natural resources in Indonesia and development of efficient strategies for the production of microbial halogenated metabolites.

Authors:  Hiroyuki Yamazaki
Journal:  J Nat Med       Date:  2021-08-20       Impact factor: 2.343

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.